Literatur

Adegbite AB, Khan MI, Paine KWE, Tan LK: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58: 51-56, 1983

Akagi K, Kurahashi H, Arita N, Hayakawa T, Monden M, Mori T, Takai SI, Nishisho I: Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 60: 178-182, 1995

Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM: Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20: 525-528 (1987)

Beks JWF, DeWindt HL: The recurrence of supratentorial meningiomas after surgery. Acta Neurochir (Vienna) 95: 3-5, 1988

Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey: Allelic loss of 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9: 296-298, 1994

Borovich B, Doron Y: Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64: 58-63, 1986

Casalone R, Simi P, Granata P, Minelli E, Giudici A, Butti G, Solero CL: Correlation between cytogenetic and histopathological findings in 65 human meningiomas. Cancer Genet Cytogenet 45: 237-243, 1990

Chan RC, Thompson GB: Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 60: 52-60, 1984

Codd MB, Kurland LT: Descriptive epidemiology of primary intracranial neoplasms. Prog Exp Tumor Res 29: 1-11, 1985

Cushing H, Eisenhardt L: Meningiomas: their classification, regional behaviour, life history, and surgical end results, Hafner, New York, 1938

DeMonte F: Current management of meningiomas. Oncol 9: 83-96, 1995

Doco-Fenzy M, Cornillet P, Scherpereel B, Depernet B, Bisiau-Leconte S, Ferre D, Pluot M, Graftiaux JP, Teyssier JR: Cytogenetic changes in 67 cranial and spinal meningiomas: relation to histopathological and clinical pattern. Anticancer Res 13: 845-850, 1993

Glaholm J, Bloom HJG, Crow JH: The role of radiotherapy in the management of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 18: 755-761, 1990

Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. J Neurosurg 80: 195-201, 1994

Henn W, Cremerius U, Heide G, Lippitz B, Schröder JM, Gilsbach JM, Büll U, Zang KD: Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet 79: 144-148, 1995

Harrison MJ, Sundaresan N: Radiation induced meningiomas. In: H. H. Schmidek (Hrsg.) Meningiomas and their surgical management. Saunders, Philadelphia, 1992

Ildan F, Tuna M, Göçer AI, Boyar B, Bagdatoglu H, Sen O, Haciyakupoglu S, Burgut R: Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas. J Neurosurg 91: 384-390, 1999

Jääskeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy and outcome. Surg Neurl 25: 233-242, 1986

Jellinger K, Slowik: Histological subtypes and prognostic problems in meningioma. J Neurol 208: 279-298, 1975

Jellinger K: Histopathological features predicting recurrence of meningiomas after (sub)total resection. Clin Neuropathol 7: 174, 1988

Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI: Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95(4): 601-7, 2001

Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3: 255-268, 1993

Kolles H, Niedermayer I, Schmitt Ch, Henn W, Feld R, Steudel WI, Zang KD, Feiden W: Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Vienna) 137: 174-181, 1995

Langford LA: Pathology of meningiomas. J Neurooncol 29: 217-221, 1996

Limon J, Dal-Cin P, Sandberg AA: Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23: 305-313, 1986

Lopez GC, Cerda NM, Bracia SJL, Llombart BA: Cytogenetical findings of recurrent meningiomas. A study of 10 tumors. Cancer Genet Cytogenet 85: 113-117, 1995

Mahmood A, Qureshi NH, Malik GM: Intracranial menigiomas: Analysis of recurrence after surgical treatment. Acta Neurochir (Vienna) 126: 53-58, 1994

Mahmood A, Caccamo DV, Tomecek FJ, Malik GM: Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33: 955-963, 1993

Mantle RE, Lach B, Delgado MR, Baeesa S, Bélanger G: Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 91: 375-386, 1999

Matsuura S, Kishi F, Kajii T: Characterization of a 5?-flanking region of the human liver/bone/kidney alkaline phosphatase gene. Biochem Biophys Res Commun 168: 993-1000, 1990

McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Meneck HR, Lawser JR: Factors associated with survival in patients with meningioma. J Neurosurg 88: 831-839, 1998

McCutcheon IE: The biology of meningiomas. J Neurooncol 29: 207-216, 1996

McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF: Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 23: 349-353, 1993

Menon GM, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW: Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative "tumor progression" locus. Oncogene 14: 611-616, 1997.

Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62: 18-24, 1985

Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.J Clin Oncol. 2006 Jun 1;24(16):2563-9.

Moller ML, Braendstrup o: No prediction of recurrence of meningiomas by PCNA and KI-67 immunohistochemistry. J Neurooncol 34: 241-246, 1997

Mueller P, Henn W, Niedermayer I, Ketter R, Feiden W, Steudel WI, Zang KD, Steilen-Gimbel H: Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 5: 3569-3577, 1999

Niedermayer I, Kolles H, Zang KD, Feiden W: Characterization of intermediate type (WHO "atypical") meningiomas. Clin Neuropathol 15: 330-336, 1996

Niedermayer I, Kolles H, Henn W, Zang KD, Steudel WI, Feiden W. [Meningioma. Classification and grading] Pathologe. 18(5): 353-8, 1997b

40. Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD: Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-assoziated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56: 879-886, 1997a

Palma L, Celli P, Franco C, Cervoni L, Cantore G: Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86: 793-800, 1997

Perry A, Jenkins RB, Dahl RJ, Moertel CA, Scheithauer BW: Cytogenetic analysis of aggressive meningiomas. Cancer 77: 2567-2573, 1996

Perry A, Stafford SL, Scheidhauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465, 1997

Petty AM, Kun LE, Meyer GA: Radiation therapy for incompletely resected meningiomas. J Neurosurg 62: 502-507, 1985.

Preston-Martin S., Paganini-Hill A., Henderson BE. et al.: Case control study of intracranial meningiomas in women in Los Angeles County. J Natl Cancer Inst 65: 67-73, 1980

Prowald A, Vater K, Ketter R, Freiler A, Henn W, Zang KD, Steudel W-I: Down-regulation of the expression of tissue-unspecific alkaline phosphatase enzyme (EC 3.1.3.1) during the progression of meningioma, Berichte aus der Medizin, 2002a

Prowald A, Vater K, Ketter R, Henn W, Zang KD, Steudel W-I: Analysis of the human liver/bone/kidney type alkaline phosphatase gene in meningiomas, J Cancer Res Clin Oncol 128 (supplement 1): 99, 2002b

Roggendorf W, Schuster T, Pfeiffer J: Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73: 361-364, 1987

Rohringer M, Sutherland GR, Louw DF, Sima AAF: Incidence and clinicopathological features of meningioma. J Neurosurg 71: 665-672, 1989

Saadi AA, Latimer F, Madercic M, Robbins T: Cytogenetic studies of human brain tumors and their clinical significance. II. Meningioma. Cancer Genet Cytogenet 26: 127-141, 1987

Scheithauer BW: Tumors of the meninges: proposed modifications of the World Health Organisation classification. Acta Neuropathol 80: 343-354, 1990

Seabright: A rapid banding technique for human chromosomes. Lancet 2: 971-972, 1971

Simon M, von Deimling A, Larson JJ, Wellenreuter R, Kaskel P, Waha A, Warnick RE, Tew JR, JM, Menon AG: Allelic loss on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55: 4696-4701, 1995

Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22-39, 1957

Soffer D, Pittaluga S, Feiner M, Beller AJ: Intracranial meningiomas following low-dose irradiation to the head. J Neurosurg 59: 1048-1053, 1983

Steilen-Gimbel H, Niedermayer I, Feiden W, Freiler A, Steudel WI, Zang KD, Henn W: Unbalanced translocation t(1;3)(p12-13;q11) in meningiomas as the unique feature of chordoid differentiation. Genes Chromosomes Cancer: 26(3):270-2, 1999

Steudel WI, Feld R, Henn W, Zang KD: Correlation between cytogenetic and clinical findings in 215 human meningiomas. Acta Neurochir [Suppl] 65: 73-76, 1996

Sutherland GR, Sima AA. : Incidence and clinicopathologic features of meningioma. In : H. H. Schmidek (Hrsg.) Meningiomas and their surgical management. Saunders Company, Philadelphia, 1992

Takeuchi H, Kubota T, Kabuto M, Kitai R, Nozaki J, Yamashita J: Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol 48: 501-506, 1997

Taylor BW, Marcus RB, Friedman WA, Ballinger WE, Million RR: The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15: 299-304 (1988)

Wara WM, Sheline GE, Newman M, Townsend JJ, Boldrey EB: Radiation therapy of meningiomas. Am J Roentgenol 123: 453-458 (1975)

Weber RG, Boström J, Wolters M, Baudis M, Collins P, Reifenberger G, Lichter P: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA Vol. 94: 14719-14724, 1997.

Weber GA, Sass C, Ketter R, Henn W, Steudel W-I, Zang KD: Mikrodissektion an Alkalische Phosphatase gefärbten Meningeomschnitten zur CGH Analyse.Berichte aus der Medizin, 2002

Weiss M, Ray K, Henthorn P, Lamb B, Kadesch T, Harris H: Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 263: 12002-12010, 1988

Younis GA, Sawaya R, Demonte F, Hess KR, Albrecht S, Brunner JM: Aggressive meningeal tumors: review of a series. J Neurosurg 82:17-27, 1995

Zang KD: Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6: 249-274, 1982

Zang KD, Singer H: Chromosomal constitution of meningiomas. Nature 216: 84-85, 1967

Zang KD: Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93(3-4): 207-20, 2001

Zankl H, Zang KD: Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1: 351-356, 1980

Zülch KJ: Histological typing of tumors of the central nervous system. Geneva, World Health Organisation 1979

Zülch KJ: Biologie und Pathologie der Hirngeschwuelste. In: Handbuch der Neurochirurgie, Bd. 3. Springer-Verlag Berlin, Goettingen, Heidelberg 1956

Wichtige Übersichtsarbeiten

Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI: Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95(4): 601-7, 2001

Zang KD: Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93(3-4): 207-20, 2001